New Delhi: The country’s first and fully indigenous corona vaccine ‘Covaxin’ may soon get approval for emergency use from the WHO. Bharat Biotech says that it has submitted all the necessary documents to the WHO on 9 July.
Bharat Biotech submitted documents
Bharat Biotech tweeted that it may soon get approval for the emergency use of Covaxin from the WHO. The company said that it has submitted all the documents related to all trials, testing and results to WHO. The company has expressed hope that soon Covaxin may also be included in the list of WHO.
These vaccines have been approved
Let us inform that so far WHO has approved Pfizer, Covishield, Moderna, Janssen, AstraZeneca and Sinoform for emergency use. At the same time, Covaxin is still out of the Emergency Use Listing (EUL) being imposed on crores of people in India.
This process has to be completed
WHO Chief Scientist Dr. Soumya Swaminathan said that a special process is followed before any drug is included in the EUL. Under this, the company has to complete all three phases of the vaccine trial and submit the data to the regulatory department of WHO.
Expert advisory group investigates
After this, the Expert Advisory Group of WHO examines this data. During testing, the safety, efficacy, manufacturing quality, standards etc. of the drug are checked. He said that a decision can be taken soon on the inclusion of Bharat Biotech’s covaccine in the EUL.